Literature DB >> 14278168

THE INITIATION AND ENHANCEMENT OF HUMAN RED CELL LYSIS BY ACTIVATORS OF THE FIRST COMPONENT OF COMPLEMENT AND BY FIRST COMPONENT ESTERASE; STUDIES USING NORMAL RED CELLS AND RED CELLS FROM PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA.

S YACHNIN, J M RUTHENBERG.   

Abstract

Entities:  

Keywords:  ANEMIA, HEMOLYTIC, ACQUIRED; CHELATING AGENTS; COMPLEMENT; DEXTRAN; ESTERASES; GAMMA GLOBULIN; HEMOGLOBINURIA, PAROXYSMAL; HEMOLYSIS; HYDROGEN-ION CONCENTRATION; PHARMACOLOGY; POLYNUCLEOTIDES; PROPERDIN; SPECTROPHOTOMETRY; STREPTODORNASE AND STREPTOKINASE

Mesh：

Substances：

Year:  1965        PMID： 14278168      PMCID： PMC292519          DOI： 10.1172/JCI105165

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  41 in total

1.  STUDIES ON HUMAN C'1-ESTERASE. I. PURIFICATION AND ENZYMATIC PROPERTIES.

Authors:  A L HAINES; I H LEPOW
Journal:  J Immunol       Date:  1964-03       Impact factor: 5.422

2.  BIOLOGIC PROPERTIES OF POLYNUCLEOTIDES. I. THE ANTICOMPLEMENTARY ACTIVITY OF POLYNUCLEOTIDES.

Authors:  S YACHNIN
Journal:  J Clin Invest       Date:  1963-12       Impact factor: 14.808

3.  Systemic lupus erythematosus. Cryoprecipitation of sera.

Authors:  C L CHRISTIAN; W B HATFIELD; P H CHASE
Journal:  J Clin Invest       Date:  1963-06       Impact factor: 14.808

4.  Measurement of human erythrocyte neuraminic acid: relationship to haemolysis and red blood cell virus interaction.

Authors:  S YACHNIN; F H GARDNER
Journal:  Br J Haematol       Date:  1961-10       Impact factor: 6.998

5.  Concerning the mechanism of complement action. V. The early steps in immune hemolysis.

Authors:  E L BECKER
Journal:  J Immunol       Date:  1960-03       Impact factor: 5.422

6.  Assay and properties of serum inhibitor of C'l-esterase.

Authors:  L R LEVY; I H LEPOW
Journal:  Proc Soc Exp Biol Med       Date:  1959 Aug-Sep

7.  The molecular characteristics determining the anticomplementary activity of dextran sulphates.

Authors:  C E TAYLOR; K W WALTON
Journal:  Br J Exp Pathol       Date:  1957-06

8.  The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena.

Authors:  L PILLEMER; L BLUM; I H LEPOW; O A ROSS; E W TODD; A C WARDLAW
Journal:  Science       Date:  1954-08-20       Impact factor: 47.728

9.  STUDIES ON DESTRUCTION OF RED BLOOD CELLS. II. CHRONIC HEMOLYTIC ANEMIA WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: CERTAIN IMMUNOLOGICAL ASPECTS OF THE HEMOLYTIC MECHANISM WITH SPECIAL REFERENCE TO SERUM COMPLEMENT.

Authors:  T H Ham; J H Dingle
Journal:  J Clin Invest       Date:  1939-11       Impact factor: 14.808

10.  ISOLATION AND DESCRIPTION OF THE FOURTH COMPONENT OF HUMAN COMPLEMENT.

Authors:  H J MUELLER-EBERHARD; C E BIRO
Journal:  J Exp Med       Date:  1963-09-01       Impact factor: 14.307
View more
  10 in total

1.  THE HEMOLYSIS OF RED CELLS FROM PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA BY PARTIALLY PURIFIED SUB-COMPONENTS OF THE THIRD COMPLEMENT COMPONENT.

Authors:  S YACHNIN
Journal:  J Clin Invest       Date:  1965-09       Impact factor: 14.808

2.  Reactive haemolysis--a distinctive form of red cell lysis.

Authors:  R A Thompson; D S Rowe
Journal:  Immunology       Date:  1968-05       Impact factor: 7.397

3.  Detection of complement components on unlysed erythrocytes from acid hemolysis and thrombin test reactions in paroxysmal nocturnal hemoglobinuria.

Authors:  D E Jenkins; W N Christenson; R L Engle
Journal:  J Clin Invest       Date:  1966-05       Impact factor: 14.808

4.  Immune lysis of normal human and paroxysmal nocturnal hemoglobinuria (PNH) red blood cells. I. The sensitivity of PNH red cells to lysis by complement and specific antibody.

Authors:  W F Rosse; J V Dacie
Journal:  J Clin Invest       Date:  1966-05       Impact factor: 14.808

5.  Serum-red cell interactions at low ionic strength: erythrocyte complement coating and hemolysis of paroxysmal nocturnal hemoglobinuria cells.

Authors:  D E Jenkins; R C Hartmann; A L Kerns
Journal:  J Clin Invest       Date:  1967-05       Impact factor: 14.808

6.  The detection of cell-bound antibody on complement-coated human red cells.

Authors:  B C Gilliland; J P Leddy; J H Vaughan
Journal:  J Clin Invest       Date:  1970-05       Impact factor: 14.808

7.  Affected erythrocytes of patients with paroxysmal nocturnal hemoglobinuria are deficient in the complement regulatory protein, decay accelerating factor.

Authors:  A Nicholson-Weller; J P March; S I Rosenfeld; K F Austen
Journal:  Proc Natl Acad Sci U S A       Date:  1983-08       Impact factor: 11.205

8.  Studies of paroxysmal nocturnal hemoglobinuria erythrocytes: increased lysis and lipid peroxide formation by hydrogen peroxide.

Authors:  C E Mengel; H E Kann; W D Meriwether
Journal:  J Clin Invest       Date:  1967-11       Impact factor: 14.808

9.  Complement-dependent platelet injury by staphylococcal protein A.

Authors:  J Hawiger; S R Marney; D G Colley; R M Des Prez
Journal:  J Exp Med       Date:  1972-07-01       Impact factor: 14.307

10.  Lysis of erythrocytes by complement in the absence of antibody.

Authors:  O Götze; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1970-11       Impact factor: 14.307
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.